Piper Sandler Expands Healthcare Investment Banking Team with the Addition of John Kerins

Piper Sandler Companies (NYSE: PIPR) has announced the appointment of John Kerins as managing director to their healthcare investment banking team.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

01/13/2025 - 09:00 AM EST

NEW YORK--(BUSINESS WIRE)-- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment banking team. Kerins will continue to serve and support clients within the pharma services sector from the firm’s New York office.

“We are excited to welcome John to the team. His transaction experience combined with strong relationships across the pharma services landscape and with the leading healthcare private equity funds investing in the category are highly complementary to our healthcare investment banking practice. Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market,” said J.P. Peltier, global group head of healthcare investment banking at Piper Sandler.

Prior to joining the firm, Kerins spent 10 years at Cain Brothers & Company, most recently as a managing director on their healthcare team advising clients on mergers and acquisitions. Before that, he was an investment banker at Deloitte for six years providing M&A advisory services. He received his bachelor’s degree from Kenyon College and his Master of Business Administration degree from Fordham University Gabelli School of Business.

“I am thrilled to be joining Piper Sandler. Their healthcare investment banking team has a trusted reputation of M&A leadership in addition to their deep healthcare services and biopharma research presence. I look forward to working with my new partners to further drive best-in-class client service,” said Kerins.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X